Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Meret Henry, Steven Buck, Batool Al-Qanber, Manisha Gadgeel & Süreyya Savaşan. (2022) Lymphocyte HLA-DR/CD-38 co-expression correlates with Hodgkin lymphoma cell cytotoxicity in vitro independent of PD-1/PD1-L pathway. Leukemia & Lymphoma 63:6, pages 1331-1338.
Read now
Read now
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, Vadim V. Ptushkin, Ana Marin-Niebla, Ramon García-Sanz, Steven Le Gouill, Anastasios Stathis, Alessia Bottos, Habib Hamidi, Pablo Katz, Thomas Perretti, Jenna C. Willis & Christian Buske. (2022) A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström’s macroglobulinemia. Leukemia & Lymphoma 63:5, pages 1058-1069.
Read now
Read now
Egor V. Batorov, Natalia V. Pronkina, Marina A. Tikhonova, Irina V. Kryuchkova, Vera V. Sergeevicheva, Svetlana A. Sizikova, Galina Y. Ushakova, Tatiana A. Aristova, Dariya S. Batorova, Irina V. Shishkova, Andrey V. Gilevich, Ekaterina Y. Shevela, Alexander A. Ostanin & Elena R. Chernykh. (2019) Increased circulating CD3+ T cells are associated with early relapse following autologous hematopoietic stem cell transplantation in patients with classical Hodgkin lymphoma. Leukemia & Lymphoma 60:10, pages 2488-2497.
Read now
Read now
Dong-Mei Zou, Dao-Bin Zhou, Yan Zhang, Wei Wang & Wei Zhang. (2019) Clinical characteristics and prognostic factors in Chinese patients with classical Hodgkin’s lymphoma involving extranodal sites: a retrospective single-center study. Hematology 24:1, pages 661-668.
Read now
Read now
Theodoros Karantanos, Ioannis Politikos & Vassiliki A Boussiotis. (2017) Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood and Lymphatic Cancer: Targets and Therapy 7, pages 37-52.
Read now
Read now
J. C. Villasboas & Stephen Ansell. (2017) Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma. Leukemia & Lymphoma 58:5, pages 1019-1021.
Read now
Read now
Articles from other publishers (19)
Arina Martynchyk, Rakin Chowdhury, Eliza A. Hawkes & Colm Keane. (2023) Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma. Cancers 15:21, pages 5217.
Crossref
Crossref
Sarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau & Noémie Lang. (2023) Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review. Biomedicines 11:6, pages 1720.
Crossref
Crossref
Vasileios Georgoulis, Alexandra Papoudou-Bai, Alexandros Makis, Panagiotis Kanavaros & Eleftheria Hatzimichael. (2023) Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications. Biology 12:6, pages 862.
Crossref
Crossref
Roberto Tamma, Giuseppe Ingravallo, Francesco Gaudio, Antonio d’Amati, Pierluigi Masciopinto, Emilio Bellitti, Loredana Lorusso, Tiziana Annese, Vincenzo Benagiano, Pellegrino Musto, Giorgina Specchia & Domenico Ribatti. (2023) The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy. Cancers 15:10, pages 2803.
Crossref
Crossref
Imen Zawati, Olfa Adouni, Maroua Manai, Majdi Nagara, Moisis Tacam, Carolina Reduzzi, Amor Gamoudi & Mohamed Manai. (2022) FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma. Human Immunology 83:12, pages 843-856.
Crossref
Crossref
Antonio Santisteban-Espejo, Irene Bernal-Florindo, Jose Perez-Requena, Lidia Atienza-Cuevas, Nieves Maira-Gonzalez & Marcial Garcia-Rojo. (2022) Whole-slide image analysis identifies a high content of Hodgkin Reed-Sternberg cells and a low content of T lymphocytes in tumor microenvironment as predictors of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD. Frontiers in Oncology 12.
Crossref
Crossref
Nurten Sayın Ekinci, Şule Darbaş & Fahri Uçar. (2022) CXCR5+CD8+ Follicular Cytotoxic T Cell Biology and Its Relationship with Diseases. Turkish Journal of Immunology 10:2, pages 48-55.
Crossref
Crossref
Fengqing Cai, Hui Gao, Zhongsheng Yu, Kun Zhu, Weizhong Gu, Xiaoping Guo, Xiaojun Xu, Hongqiang Shen & Qiang Shu. (2022) High percentages of peripheral blood T-cell activation in childhood Hodgkin's lymphoma are associated with inferior outcome. Frontiers in Medicine 9.
Crossref
Crossref
Victoria Menéndez, José L. Solórzano, Sara Fernández, Carlos Montalbán & Juan F. García. (2022) The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. Cancers 14:5, pages 1360.
Crossref
Crossref
Melissa Alame, Marion Pirel, Valérie Costes-Martineau, Luc Bauchet, Michel Fabbro, Alicia Tourneret, Laura De Oliveira, Luc Durand, Pascal Roger, Samia Gonzalez, Valère Cacheux, Valérie Rigau & Vanessa Szablewski. (2019) Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas. Virchows Archiv 476:6, pages 891-902.
Crossref
Crossref
Paul J. Bröckelmann & Lena Specht. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
145
169
.
Lydia Visser, Johanna Veldman, Sibrand Poppema, Anke van den Berg & Arjan Diepstra. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
69
86
.
María José Godoy-Calderón, Eglys González-Marcano, Jeismar Carballo & Ana Federica Convit. (2019) Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment. Oncotarget 10:61, pages 6546-6560.
Crossref
Crossref
Melita Cirillo, Sarah Reinke, Wolfram Klapper & Sven Borchmann. (2019) The translational science of hodgkin lymphoma. British Journal of Haematology 184:1, pages 30-44.
Crossref
Crossref
Meret Henry, Steven Buck & Süreyya Savaşan. (2018) Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma. Pediatric Blood & Cancer 65:11, pages e27307.
Crossref
Crossref
María José Godoy-Calderón, Víctor Salazar, Eglys González-Marcano & Ana Federica Convit. (2018) Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response. Oncotarget 9:29, pages 20222-20238.
Crossref
Crossref
Peter Hollander, Klaus Rostgaard, Karin E. Smedby, Daniel Molin, Angelica Loskog, Peter de Nully Brown, Gunilla Enblad, Rose-Marie Amini, Henrik Hjalgrim & Ingrid Glimelius. (2018) An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome. European Journal of Haematology 100:1, pages 88-97.
Crossref
Crossref
C. Yang, H. Cheng, G. Luo, Y. Lu, M. Guo, K. Jin, Z. Wang, X. Yu & C. Liu. (2017) The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system. European Journal of Surgical Oncology 43:11, pages 2112-2118.
Crossref
Crossref
Federico Perdomo-Celis, Natalia Andrea Taborda & María Teresa Rugeles. (2017) Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection. Frontiers in Immunology 8.
Crossref
Crossref